News | Artificial Intelligence | August 10, 2023

Blackford and AI4MedImaging Announce Partnership to enhance AI solutions offering for Cardiac MRI

Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform 

Partnership makes AI4MedImaging’s AI4CMR solution available on the Blackford Platform

August 10, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a cardiac MRI solution provider announce a partnership to make the AI4CMR solution available on the Blackford Platform. AI4CMR will enable Blackford customers to automatically segment and quantify cardiac MRI measurements. 

"Blackford’s mission is to deliver AI that provides value to healthcare providers to increase efficiency and improves patient outcomes,” said Blackford CEO Ben Panter. “We are excited to increase our cardiac MRI solution offering on the Blackford Platform with AI4MedImaging.” 

AI4CMR uses artificial intelligence to calculate, quantify, and analyse the left and right ventricle within 2 minutes, and produces a structured report to be extracted to any reporting system. It also provides a triage functionality for wall motion detection (this functionality is CE marked and FDA-pending). 

“AI4MedImaging is thrilled to partner with Blackford and contribute to the democratization of Cardiac Magnetic Resonance. With AI4CMR, the first cardiac AI to receive CE and FDA approval, analysis is fast, accurate, made-easy and available at any location due to the web-based cloud technology used,” said AI4MedImaging’s CEO and MD Vítor Pereira. 

For more information: www.blackfordanalysis.com


Related Content

News | FDA

Dec.1, 2025 – MannKind Corp. has announced that the U.S. Food and Drug Administration (FDA) has accepted the sNDA ...

Home December 01, 2025
Home
News | FDA

Nov. 18, 2025 — RapidAI announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the ...

Home November 18, 2025
Home
News | FDA

Nov. 11, 2025 -— Integra LifeSciences Holdings Corp. has announced the FDA 510(k) clearance for use of its CUSA Clarity ...

Home November 18, 2025
Home
News | FDA

Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...

Home November 11, 2025
Home
News | FDA

Oct. 29, 2025 — Circle Cardiovascular Imaging Inc., a provider of cardiovascular imaging solutions, recently announced ...

Home November 03, 2025
Home
News | FDA

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Home October 27, 2025
Home
News | FDA

Oct. 16, 2025 — Thirona recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Home October 16, 2025
Home
News | FDA

Oct. 14, 2025 — Nurea has announced that its PRAEVAorta 2 software has received FDA 510(k) clearance, enabling entry ...

Home October 14, 2025
Home
News | FDA

July 7, 2025 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval to expand the ...

Home July 08, 2025
Home
News | FDA

June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...

Home June 12, 2025
Home
Subscribe Now